image
Healthcare - Medical - Care Facilities - NASDAQ - US
$ 4.82
1.05 %
$ 940 M
Market Cap
-79.83
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on May, 7, 2025.

The intrinsic value of one AVAH stock under the worst case scenario is HIDDEN Compared to the current market price of 4.82 USD, Aveanna Healthcare Holdings Inc. is HIDDEN

This DCF valuation model was last updated on May, 7, 2025.

The intrinsic value of one AVAH stock under the base case scenario is HIDDEN Compared to the current market price of 4.82 USD, Aveanna Healthcare Holdings Inc. is HIDDEN

This DCF valuation model was last updated on May, 7, 2025.

The intrinsic value of one AVAH stock under the best case scenario is HIDDEN Compared to the current market price of 4.82 USD, Aveanna Healthcare Holdings Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart AVAH

image
$6.0$6.0$5.5$5.5$5.0$5.0$4.5$4.5$4.0$4.0$3.5$3.515 Nov15 NovDec '24Dec '2415 Dec15 DecJan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '2515 Apr15 AprMay '25May '25
FINANCIALS
2.02 B REVENUE
6.82%
140 M OPERATING INCOME
1631.75%
-10.9 M NET INCOME
91.88%
32.6 M OPERATING CASH FLOW
43.95%
-6.32 M INVESTING CASH FLOW
28.14%
14 M FINANCING CASH FLOW
29.33%
520 M REVENUE
2.13%
45.8 M OPERATING INCOME
34.53%
29.2 M NET INCOME
168.11%
13.4 M OPERATING CASH FLOW
-54.39%
-1.53 M INVESTING CASH FLOW
30.91%
-6.05 M FINANCING CASH FLOW
-167.15%
Balance Sheet Aveanna Healthcare Holdings Inc.
image
Current Assets 393 M
Cash & Short-Term Investments 84.3 M
Receivables 278 M
Other Current Assets 30.7 M
Non-Current Assets 1.27 B
Long-Term Investments 0
PP&E 58.7 M
Other Non-Current Assets 1.21 B
5.07 %16.69 %3.53 %72.87 %Total Assets$1.7b
Current Liabilities 402 M
Accounts Payable 36.4 M
Short-Term Debt 14.4 M
Other Current Liabilities 351 M
Non-Current Liabilities 1.38 B
Long-Term Debt 1.27 B
Other Non-Current Liabilities 112 M
19.68 %71.22 %6.25 %Total Liabilities$1.8b
EFFICIENCY
Earnings Waterfall Aveanna Healthcare Holdings Inc.
image
Revenue 2.02 B
Cost Of Revenue 1.39 B
Gross Profit 636 M
Operating Expenses 496 M
Operating Income 140 M
Other Expenses 151 M
Net Income -10.9 M
3b3b2b2b2b2b1b1b500m500m00(500m)(500m)2b(1b)636m(496m)140m(151m)(11m)RevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
31.39% GROSS MARGIN
31.39%
6.90% OPERATING MARGIN
6.90%
-0.54% NET MARGIN
-0.54%
8.95% ROE
8.95%
-0.66% ROA
-0.66%
-23.61% ROIC
-23.61%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Aveanna Healthcare Holdings Inc.
image
120m120m100m100m80m80m60m60m40m40m20m20m00(20m)(20m)(40m)(40m)(60m)(60m)(80m)(80m)201920192020202020212021202220222023202320242024
Net Income -10.9 M
Depreciation & Amortization 31.2 M
Capital Expenditures -6.32 M
Stock-Based Compensation 17.5 M
Change in Working Capital -30 M
Others 16.1 M
Free Cash Flow 26.3 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Aveanna Healthcare Holdings Inc.
image
Wall Street analysts predict an average 1-year price target for AVAH of $4.25 , with forecasts ranging from a low of $2 to a high of $6 .
AVAH Lowest Price Target Wall Street Target
2 USD -58.51%
AVAH Average Price Target Wall Street Target
4.25 USD -11.83%
AVAH Highest Price Target Wall Street Target
6 USD 24.48%
Price
Max Price Target
Min Price Target
Average Price Target
666655554444333322Jun '24Jun '24Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
4. DIVIDEND ANALYSIS
5. COMPETITION
slide 2 of 12
6. Ownership
Insider Ownership Aveanna Healthcare Holdings Inc.
image
Sold
0-3 MONTHS
2.72 M USD 3
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
Aveanna to Participate at the RBC 2025 Global Healthcare Conference ATLANTA, April 29, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that its management team will attend the RBC 2025 Global Healthcare Conference in New York on May 20, 2025. globenewswire.com - 2 weeks ago
4 Cheap Stocks With Solid Fundamentals to Offset Market Uncertainty Here we discuss four stocks with strong fundamentals with attractive valuation following recent decline. These are AVAH, CALM, COMM and STRL. zacks.com - 3 weeks ago
Aveanna Announces First Quarter 2025 Earnings Release Date and Conference Call ATLANTA, April 17, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that the company will release its first quarter results before the market open on Thursday, May 8, 2025, to be followed by a conference call at 10:00 a.m. (Eastern Time) on the same day. globenewswire.com - 1 month ago
Aveanna Healthcare Holdings Announces Agreement to Acquire Thrive Skilled Pediatric Care ATLANTA, April 03, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced that it has entered into an agreement to acquire Thrive Skilled Pediatric Care ("Thrive SPC"). The transaction is expected to close in the second fiscal quarter of 2025, subject to customary regulatory approvals. globenewswire.com - 1 month ago
Fast-paced Momentum Stock Aveanna (AVAH) Is Still Trading at a Bargain Aveanna (AVAH) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices. zacks.com - 1 month ago
AVAH Surges 45% in Five Days: How to Play the Stock After Earnings? Aveanna Healthcare AVAH shares surged 45.1% in the past trading sessions, regaining their 50-day moving average, which indicates strength in the stock. AVAH released its fourth-quarter 2024 results on March 13, reporting robust revenue growth alongside improved gross margin. zacks.com - 2 months ago
Aveanna (AVAH) Surges 6.2%: Is This an Indication of Further Gains? Aveanna (AVAH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term. zacks.com - 2 months ago
Are Medical Stocks Lagging Aveanna Healthcare (AVAH) This Year? Here is how Aveanna Healthcare (AVAH) and Equillium, Inc. (EQ) have performed compared to their sector so far this year. zacks.com - 2 months ago
Aveanna Healthcare Holdings Inc. (AVAH) Q4 2024 Earnings Call Transcript Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH ) Q4 2024 Earnings Conference Call March 13, 2025 10:00 AM ET Company Participants Debbie Stewart - Chief Accounting Officer Jeff Shaner - Chief Executive Officer Matt Buckhalter - Chief Financial Officer and Principal Financial Officer Conference Call Participants Megan Holt - Jefferies Michael Murray - RBC Capital Markets Benjamin Rossi - JPMorgan Chase & Company Scott Fidel - Stephen Kieran Ryan - Deutsche Bank Operator Good morning, and welcome to Aveanna Healthcare Holdings Fourth Quarter 2024 Earnings Conference Call. Today's call is being recorded and we have allocated one hour for prepared remarks and Q&A. seekingalpha.com - 2 months ago
Home Care Platform Aveanna Healthcare Reports Quarterly Profit, Expects Organic Volume Growth, Enhanced Profitability Into 2025 Aveanna Healthcare Holdings Inc. AVAH reported on Thursday fourth-quarter adjusted EPS of five cents, a turnaround from a loss of two cents. benzinga.com - 2 months ago
Aveanna (AVAH) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates While the top- and bottom-line numbers for Aveanna (AVAH) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values. zacks.com - 2 months ago
3 Healthcare Stocks With Strong EPS Growth Potential to Buy in 2025 GILD, OPCH and AVAH demonstrate resilience with impressive earnings surprise history. zacks.com - 2 months ago
8. Profile Summary

Aveanna Healthcare Holdings Inc. AVAH

image
COUNTRY US
INDUSTRY Medical - Care Facilities
MARKET CAP $ 940 M
Dividend Yield 0.00%
Description Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides private duty nursing (PDN), adult home health and hospice, home-based pediatric therapy, and enteral nutrition services in the United States. Its patient- centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers PDN services, which include in-home skilled nursing services to medically fragile children; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and employer of record support and personal care services, as well as in-clinic and home-based pediatric therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers enteral nutrition supplies and other products to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.
Contact 400 Interstate North Parkway SE, Atlanta, GA, 30339 https://www.aveanna.com
IPO Date April 28, 2021
Employees 33500
Officers Ms. Deborah Stewart Senior Vice President & Principal Accounting Officer Mr. Rodney D. Windley Executive Chairman Mr. Matthew Buckhalter Chief Financial Officer & Principal Financial Officer Mr. Jeffrey S. Shaner Chief Executive Officer & Director Ms. Rachel Witt Chief Clinical Officer Ms. Kristy Rohwedder Chief Operating Officer Mr. Jerry Perchik Chief Legal Officer & Secretary Mr. Patrick A. Cunningham Chief Compliance Officer Mr. Shane Brinkerhoff President of Home Health & Hospice Mr. Ed Reisz Chief Administrative Officer